✦ LIBER ✦

Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)

✍ Scribed by V.T. Ho; E. Hochberg; D. Zahrieh; C. Cutler; S. Steckel; S.J. Lee; E.P. Alyea; J. Ritz; R.J. Soiffer; J.H. Antin

Book ID: 116277552
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 47 KB
Volume: 10
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2003.12.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab for steroid refractory or dep

Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation

✍ Jun Yang; Daniel Ka Leung Cheuk; Shau Yin Ha; Alan Kwok Shing Chiang; Tsz Leung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Induction of graft-versus-autoimmune (GV

Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ Kojima, R; Kami, M; Kim, S-W; Murashige, N; Kishi, Y; Hori, A; Imataki, O; Hamak 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

318: Extracorporeal photopheresis (ECP)

318: Extracorporeal photopheresis (ECP) for the treatment of steroid-refractory or -intolerant chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (HSCT)

✍ A. Pawarode; T. Hahn; M. Battiwalla; P.L. McCarthy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat

Extracorporeal photopheresis therapy in

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

✍ Apisarnthanarax, N; Donato, M; Körbling, M; Couriel, D; Gajewski, J; Giralt, S; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

340: Response to Steroids as Primary The

340: Response to Steroids as Primary Therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem Cell Transplant (HSCT) Recipients: Comparison of Unrelated Donor (URD) Bone Marrow (BM) and Umbilical Cord Blood (UCB)

✍ M.L. MacMillan; J.E. Wagner; M. Arora; T.E. DeFor; B.R. Blazar; D.J. Weisdorf 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB